Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
Background: Methotrexate (MTX) is widely used for rheumatoid arthritis (RA) treatment. Single nucleotide polymorphisms (SNPs) could be used as predictors of patients’ therapeutic outcome variability. Therefore, this study aims to evaluate the influence of SNPs in genes encoding for MTX membrane tran...
Main Authors: | Aurea Lima, Miguel Bernardes, Rita Azevedo, Rui Medeiros, Vítor Seabra |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/6/13760 |
Similar Items
-
Methotrexate in Treatment of Rheumatoid Arthritis
by: Wiewiόrowski Maciej, et al.
Published: (1999-08-01) -
Relationship between methotrexate dose and clinical efficacy for treatment of rheumatoid arthritis
by: HE Longquan, et al.
Published: (2020-09-01) -
Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
by: Almalag H, et al.
Published: (2020-09-01) -
Analysis of association of -174G/C interleukin 6 polymorphism and therapeutic response to methotrexate in rheumatoid arthritis
by: Joksimović Anastasija, et al.
Published: (2018-01-01) -
Genetic polymorphism of the methotrexate transporter ABCG2, blood pressure and markers of arterial function in patients with rheumatoid arthritis: repeated cross-sectional study
by: Baghdadi LR, et al.
Published: (2018-11-01)